Iomeron (Iomeprol)

Iomeron, containing iomeprol, is employed as an iodinated contrast medium for various diagnostic imaging procedures that visualize vascular and organ structures.

• CT Angiography: improves delineation of arterial and venous vessels for accurate diagnosis.
• Cardiac catheterization: enhances visualization of coronary arteries and cardiac chambers during invasive procedures.
• Intravenous urography: highlights the urinary tract, facilitating detection of obstruction or lesions.
• Peripheral angiography: provides clear imaging of limb vessels for assessment of peripheral vascular disease.

• Iomeprol is a water‑soluble, non‑ionic iodinated compound that contains multiple iodine atoms. After intravenous or intra‑arterial injection, it distributes rapidly within the extracellular fluid and remains largely within the vascular compartment. The high atomic number of iodine strongly absorbs X‑ray photons, increasing the radiodensity of blood and tissues. This temporary enhancement allows detailed X‑ray, CT, or fluoroscopic images of anatomical structures.

Iomeprol may be associated with a range of adverse reactions, varying from mild and transient to severe and life‑threatening.

Common Side Effects

• Warm sensation or flushing at the injection site.
• Nausea or vomiting.
• Mild headache.
• Metallic taste in the mouth.

Serious or Rare Side Effects

• Anaphylactic or severe allergic reaction.
• Acute kidney injury, especially in patients with pre‑existing renal impairment.
• Severe hypotension or cardiovascular collapse.
• Pulmonary edema or respiratory distress.

When using Iomeron, clinicians should observe specific precautions to minimize risk and ensure patient safety.

• Assess renal function: evaluate serum creatinine and eGFR before administration.
• Screen for iodine or contrast allergy: obtain detailed allergy history.
• Monitor vital signs: observe blood pressure and heart rate during and after injection.
• Use the lowest effective dose: adjust volume based on patient size and imaging requirements.
• Avoid in uncontrolled hyperthyroidism: iodine load may exacerbate thyroid hormone release.
• Store at ambient temperature: keep below 25 °C, retain original packaging, protect from moisture and light.

Iomeron can interact with certain medications, affecting safety or efficacy; awareness of these interactions guides appropriate management.

Major Interactions (Avoid)

• Metformin: risk of lactic acidosis in renal impairment; discontinue before contrast.
• Aminoglycoside antibiotics: combined nephrotoxic potential.
• Iodine‑containing thyroid medications: may cause thyroid dysfunction.

Moderate Interactions (Monitor Closely)

• Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase risk of contrast‑induced nephropathy; ensure adequate hydration.
• Diuretics: may potentiate renal effects; monitor fluid balance.
• Beta‑blockers: may mask hypotensive responses; observe hemodynamics.